Trial
NCT05275907
Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
Phase IVWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Northwestern University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); American Society for Transplantation
Condition
High Blood Pressure
Intervention
Amlodipine Besylate
Why stopped
Screened participants did not meet inclusion criteria prior to study completion date
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-13